Surgical Innovations Group plc provided earnings guidance for the financial year ended December 31, 2012. For the period, total revenue reported for full year ended December 31, 2012 is now expected to be £7.6 million compared to £7.6 million a year ago. Gross margins are expected to have improved by three basis points to 50.3% compared to 47.3% a year ago.

Adjusted EBITDA is ahead of the previous year at £2.85 million compared to £2.8 million a year ago.